Efficacy and safety of Glycoprotein IIb/IIIa receptor antagonists in patients with infarct-related cardiogenic shock

Abdin, Amr2023-08-012023-08-012019https://epub.uni-luebeck.de/handle/zhb_hl/2239enCardiogenic shockPatientsEnemiesMyocardial infarction610Efficacy and safety of Glycoprotein IIb/IIIa receptor antagonists in patients with infarct-related cardiogenic shockthesis.doctoral117616046X104874454Xurn:nbn:de:gbv:841-20181101354